Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults
Hagit Kopel, Văn Hùng Nguyễn, Cathérine Boileau, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1711-1711
Open Access | Times Cited: 22
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Mélanie Closset, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 7
Relative Effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines and Homologous Boosting in Preventing COVID-19 in Adults in the US
Văn Hùng Nguyễn, Cathérine Boileau, Alina Bogdanov, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 19
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults in the United States
Hagit Kopel, Văn Hùng Nguyễn, Cathérine Boileau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread
Himanshu Ajmera, Sudarshan Singh Lakhawat, Naveen Malik, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 4, pp. 307-325
Closed Access | Times Cited: 2
Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults
Anne T. Gelderloos, Marije K. Verheul, Irene Middelhof, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants
Lok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
EBioMedicine (2024) Vol. 110, pp. 105461-105461
Open Access | Times Cited: 2
Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study
Jessica A. Breznik, Ahmad Rahim, Hina Bhakta, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 5
Profiling the SARS-CoV-2-specific T-cell response
Daryl Geers, Lennert Gommers, Ngoc H. Tan, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. e477-e478
Closed Access | Times Cited: 1
Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers
Isabell Wagenhäuser, Giovanni Almanzar, Franziska Bernhardine Förg, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126132-126132
Open Access | Times Cited: 1
Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants
Holly A. Fryer, Daryl Geers, Lennert Gommers, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106246-106246
Open Access | Times Cited: 1
Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
Andrey V. Vasin, Marina Stukova
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 8, pp. 880-881
Open Access | Times Cited: 4
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Mélanie Closset, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 3
COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
Wei‐Chun Chen, Shu-Yu Hu, Ching‐Fen Shen, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1425-1425
Open Access | Times Cited: 3
Distinct COVID-19 vaccine combinations result in divergent immune responses
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Hie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants
Holly A. Fryer, Daryl Geers, Lennert Gommers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands
Marlou J. Jongkees, Ngoc H. Tan, Daryl Geers, et al.
AIDS (2024) Vol. 38, Iss. 9, pp. 1355-1365
Open Access
Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trial
Ngoc H. Tan, Melvin Lafeber, Roos S. G. Sablerolles, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access
Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton Syndrome
Anouk E. M. Nouwen, Luca M. Zaeck, Renske Schappin, et al.
Journal of Clinical Immunology (2024) Vol. 45, Iss. 1
Open Access
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1238-1238
Open Access
The effect of sleep and shift work on the primary immune response to messenger RNA‐based COVID‐19 vaccination
Tamara M. J. Brouwers, Ümmü Gülsüm Çobanoğlu, Daryl Geers, et al.
Journal of Sleep Research (2024)
Open Access
Page 1 - Next Page

Scroll to top